By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NeuroVive Pharmaceutical AB 

Biomedical Center

Sölvegatan 19    SE-221 84 Lund  Sweden
Phone: 46-0-46-288-0110 Fax: 46-0-46-888-8348


SEARCH JOBS

NeuroVive Pharmaceutical is a pioneer in mitochondrial research and development. The focus is on developing drug candidates that maintain mitochondrial integrity and improves their function for indications with unmet medical needs. Research and development is conducted both in-house and in collaboration with renowned international partners.

YEAR FOUNDED:

2000

LEADERSHIP:

Founder: Eskil Elmér

CEO: Erik Kinnman

CSO and Founder: Eskil Elmér


Key Statistics


Email: info@neurovive.com
Ownership: Public

Web Site: NeuroVive
Employees:
Symbol: NVP
 



Industry
Pharmaceutical






Company News
NeuroVive (NVP)'s COO Resigns 8/24/2016 5:47:33 AM
NeuroVive (NVP) - Interim Report January-June 2016 8/18/2016 1:47:03 PM
NeuroVive (NVP) Completes 10 Percent Acquisition Of Isomerase Therapeutics 8/15/2016 9:42:26 AM
NeuroVive (NVP)’s Novel Strategy For Treatment Of Mitochondrial Disease Published In Nature Communications 8/9/2016 10:05:13 AM
NeuroVive (NVP) Announces Arbutus Biopharma (ABUS)’s Notice Of Termination 7/6/2016 10:05:04 AM
NeuroVive (NVP) Announces CiPRICS Study Completes Enrollment 6/7/2016 10:58:59 AM
NeuroVive (NVP) Share Upgraded To OTC Markets Group – OTCQX Best Market In The U.S. 6/2/2016 11:27:05 AM
NeuroVive (NVP) (Publ) - Amendment Number Of Shares And Votes 5/31/2016 1:16:36 PM
NeuroVive (NVP): Interim Report 1 Jan. 2016 To 31 Mar. 2016 5/31/2016 11:36:14 AM
NeuroVive (NVP) (publ): Report From AGM 4/29/2016 1:26:53 PM
12345678910
//-->